SenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a report released on Thursday. The firm set a “sell” rating on the stock.

SenesTech Price Performance

Shares of NASDAQ:SNES opened at $0.84 on Thursday. The company’s 50 day simple moving average is $0.77 and its 200 day simple moving average is $1.27. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.49 and a quick ratio of 7.48. SenesTech has a 1 year low of $0.52 and a 1 year high of $17.52.

Institutional Trading of SenesTech

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC acquired a new stake in shares of SenesTech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech as of its most recent SEC filing. 5.19% of the stock is owned by hedge funds and other institutional investors.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.